The current valuation score of Spero Therapeutics Inc is 6.99, ranking 258 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 4.30, which is 334.29% below the recent high of 18.69 and 194.26% above the recent low of -4.06.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.